We found that the OS time of the ATM-MT bladder cancer patients treated with ICIs was longer than that of the ATM-WT patients [Figure 1A, hazard ratio (HR) = 0.28, [95% confidence interval (CI), 0.16 to 0.51], P = 0.007]. The gene discussed is ATM; the disease is urinary bladder cancer.